|
1.
|
M Wills-KarpJ LuyimbaziX XuB
SchofieldInterleukin-13: central mediator of allergic
asthmaScience28222582261199810.1126/science.282.5397.22589856949
|
|
2.
|
FD FinkelmanSP HoganGK HersheyME
RothenbergM Wills-KarpImportance of cytokines in murine allergic
airway disease and human asthmaJ
Immunol18416631674201010.4049/jimmunol.090218520130218
|
|
3.
|
Q HamidM TulicImmunobiology of asthmaAnnu
Rev Physiol71489507200910.1146/annurev.physiol.010908.163200
|
|
4.
|
G GrünigM WarnockAE WakilRequirement for
IL-13 independently of IL-4 in experimental
asthmaScience2822261226319989856950
|
|
5.
|
G YangL LiA VolkTherapeutic dosing with
anti-interleukin-13 monoclonal antibody inhibits asthma progression
in miceJ Pharmacol Exp
Ther313815200510.1124/jpet.104.07613315644434
|
|
6.
|
MT KasaianDK MillerIL-13 as a therapeutic
target for respiratory diseaseBiochem
Pharmacol76147155200810.1016/j.bcp.2008.04.00218502398
|
|
7.
|
S HolgateA ChuchalinJ HebertEfficacy and
safety of a recombinant anti-immunoglobulin E antibody (omalizumab)
in severe allergic asthmaClin Exp
Allergy34632638200410.1111/j.1365-2222.2004.1916.x15080818
|
|
8.
|
WJ SandbornNew concepts in anti-tumor
necrosis factor therapy for inflammatory bowel diseaseRev
Gastroenterol Disord51018200515741928
|
|
9.
|
Y MaKT HayGlassAB BeckerNovel recombinant
interleukin-13 peptide-based vaccine reduces airway allergic
inflammatory responses in miceAm J Respir Crit Care
Med176439445200710.1164/rccm.200610-1405OC17556715
|
|
10.
|
M Wills-KarpImmunologic basis of
antigen-induced airway hyperresponsivenessAnnu Rev
Immunol17255281199910.1146/annurev.immunol.17.1.25510358759
|
|
11.
|
M Wills-KarpInterleukin-13 in asthma
pathogenesisImmunol
Rev202175190200410.1111/j.0105-2896.2004.00215.x
|
|
12.
|
PJ SabbatiniG RagupathiC HoodPilot study
of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus
QS21 in patients with epithelial ovarian, fallopian tube, or
peritoneal cancerClin Cancer
Res1341704177200710.1158/1078-0432.CCR-06-2949
|
|
13.
|
H Le BuanecD ZaguryStable immunogenic
product comprising antigenic heterocomplexesUS Patent 7972603.
Filed Septemper 16, 2003; issued July 5, 2011
|
|
14.
|
FH RadH Le BuanecS PaturanceVEGF kinoid
vaccine, a therapeutic approach against tumor angiogenesis and
metastasesProc Natl Acad Sci
USA10428372842200710.1073/pnas.061102210417301234
|
|
15.
|
YG KwakCH SongHK YiInvolvement of PTEN in
airway hyperresponsiveness and inflammation in bronchial asthmaJ
Clin Investig11110831092200310.1172/JCI1644012671058
|
|
16.
|
Y MaAG MaZ PengA potential immunotherapy
approach: mucosal immunization with an IL-13 peptide-based
virus-like particle vaccine in a mouse asthma
modelVaccine2580918099200710.1016/j.vaccine.2007.09.00917935839
|
|
17.
|
JY MaS MedicherlaI KerrR MangaduAA
ProtterLS HigginsSelective p38-α mitogen-activated protein kinase
inhibitor attenuates lung inflammation and fibrosis in IL-13
transgenic mouse model of asthmaJ Asthma Allergy131442008
|
|
18.
|
H MilgromB BenderL AckersonP BowryB SmithC
RandNoncompliance and treatment failure in children with asthmaJ
Allergy Clin
Immunol9810511057199610.1016/S0091-6749(96)80190-48977504
|
|
19.
|
C RandR WiseM NidesMetered-dose inhaler
adherence in a clinical trialAm Rev Respir
Dis14615591564199210.1164/ajrccm/146.6.15591456575
|
|
20.
|
D GrayH SkarvallB-cell memory is
short-lived in the absence of
antigenNature3367073199810.1038/336070a03263573
|
|
21.
|
S HolgateT CasaleS WenzelJ BousquetY
DenizC ReisnerThe anti-inflammatory effects of omalizumab confirm
the central role of IgE in allergic inflammationJ Allergy Clin
Immunol115459465200510.1016/j.jaci.2004.11.05315753888
|
|
22.
|
CL EmsonSE BellA JonesW WisdenAN
McKenzieInterleukin (IL)-4-independent induction of immunoglobulin
(Ig) E, and perturbation of T cell development in transgenic mice
expressing IL-13J Exp
Med188399404199810.1084/jem.188.2.3999670052
|
|
23.
|
LA BeckGV MarcotteD MacGlashanA TogiasS
SainiOmalizumab-induced reductions in mast cell FcεRI expression
and functionJ Allergy Clin Immunol114527530200415356552
|
|
24.
|
C PrussinDT GriffithKM BoeselH LinB
FosterTB CasaleOmalizumab treatment downregulates dendritic cell
FcεRI expressionJ Allergy Clin Immunol11211471154200315753888
|
|
25.
|
MM EpsteinDo mouse models of allergic
asthma mimic clinical disease?Int Arch Allergy
Immunol13384100200010.1159/00007613114726635
|
|
26.
|
JJ LeeD DiminaMP MaciasDefining a link
with asthma in mice congenitally deficient in
eosinophilsScience30517731776200410.1126/science.109947215375267
|
|
27.
|
K DabbaghK TakeyamaHM LeeIF UekiJA
LausierJA NadelIL-4 induces mucin gene expression and goblet cell
metaplasia in vitro and in vivoJ Immunol16262336237199910229869
|
|
28.
|
C AgustiK TakeyamaLO CardellGoblet cell
degranulation after antigen challenge in sensitized guinea pigs.
Role of neutrophilsAm J Respir Crit Care
Med15812531258199810.1164/ajrccm.158.4.98010419769289
|
|
29.
|
M DunnillThe pathology of asthma, with
special reference to changes in the bronchial mucosaJ Clin
Pathol132733196010.1136/jcp.13.1.2713818688
|
|
30.
|
S ShimuraY AndohM HaraguchiK
ShiratoContinuity of airway goblet cells and intraluminal mucus in
the airways of patients with bronchial asthmaEur Respir
J913951401199610.1183/09031936.96.090713958836649
|
|
31.
|
T AikawaS ShimuraH SasakiM EbinaT
TakishimaMarked goblet cell hyperplasia with mucus accumulation in
the airways of patients who died of severe acute asthma
attackChest101916921199210.1378/chest.101.4.9161555462
|
|
32.
|
T NakanoH InoueS FukuyamaNiflumic acid
suppresses interleukin-13-induced asthma phenotypesAm J Respir Crit
Care Med17312161221200610.1164/rccm.200410-1420OC16528019
|
|
33.
|
A KibeH InoueS FukuyamaDifferential
regulation by glucocorticoid of interleukin-13-induced
eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in
mouse airwaysAm J Respir Crit Care
Med1675056200310.1164/rccm.211008412502476
|
|
34.
|
PC FulkersonCA FischettiLM HassmanNM
NikolaidisME RothenbergPersistent effects induced by IL-13 in the
lungAm J Respir Cell Mol
Biol35337346200610.1165/rcmb.2005-0474OC16645178
|
|
35.
|
Z ZhuRJ HomerZ WangPulmonary expression of
interleukin-13 causes inflammation, mucus hypersecretion,
subepithelial fibrosis, physiologic abnormalities, and eotaxin
productionJ Clin Investig103779788199910.1172/JCI5909
|
|
36.
|
DM WalterJJ McIntireG BerryCritical role
for IL-13 in the development of allergen-induced airway
hyperreactivityJ
Immunol16746684675200110.4049/jimmunol.167.8.466811591797
|
|
37.
|
H Le BuanecL DelavalléeN BessisTNFα kinoid
vaccination-induced neutralizing antibodies to TNFα protect mice
from autologous TNFα-driven chronic and acute inflammationProc Natl
Acad Sci USA10319442194472006
|
|
38.
|
D ZaguryH Le BuanecA MathianIFNα kinoid
vaccine-induced neutralizing antibodies prevent clinical
manifestations in a lupus flare murine modelProc Natl Acad Sci
USA106529452992009
|
|
39.
|
RS KerbelBA KamenThe anti-angiogenic basis
of metronomic chemotherapyNat Rev
Cancer4423436200410.1038/nrc136915170445
|
